匯控(00005.HK)等13間金融機構同意就美房貸機構債券操控案和解
《路透》報道,13間金融機構就操控美房貸機構房利美(Fannie Mae)及房貸美(Freddie Mac)債券價格與達成和解,合共3.37億美元,協議有待美國曼克頓聯邦法院法官批准。
其中承銷最多相關債券的巴克萊支付8,700萬美元,其餘12間金融機構支付共2.5億美元,包括美銀、法巴、建達資本(Cantor Fitzgerald)、花旗、瑞信、匯控(00005.HK)、摩根大通、摩根士丹利、野村、法興、多倫多道明及瑞銀。
德銀、高盛及First Horizon早前已同意支付4,950萬美元和解費用。
該等金融機構被指在2009年1月及2019年1月期間,利用市場壟斷獲利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.